Related Experiment Video
Updated: Dec 5, 2025

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Atypical Large Vessel Vasculitis Presenting With Cholestatic Liver Abnormalities: Case-Based Review
Sameet Sangha1, Aleksander Lenert1, Salma Dawoud1
1From the Divisions of Immunology.
Insights
Atypical large vessel vasculitis (LVV) can present with unusual symptoms, including liver enzyme elevations. Prompt immunosuppressive treatment can rapidly improve alkaline phosphatase levels in these patients.
Area of Science:
- Rheumatology
- Vascular Medicine
- Hepatology
Background:
- Giant cell arteritis (GCA) typically presents with cranial symptoms, but atypical large vessel vasculitis (LVV) can manifest with a broader range of signs.
- LVV can affect various blood vessels beyond the temporal arteries, including coronary, aortic, intracranial, and hepatic arteries.
- Constitutional symptoms like fever of unknown origin in LVV can mimic neoplastic or infectious diseases, complicating diagnosis.
Purpose of the Study:
- To highlight the diagnostic challenges of atypical large vessel vasculitis (LVV).
- To underscore the significance of liver enzyme abnormalities in the presentation of LVV.
- To illustrate the effectiveness of immunosuppressive therapy in managing LVV-associated hepatic manifestations.
Main Methods:
- Review of three patients with eventually diagnosed atypical LVV.
- Diagnostic confirmation through temporal artery biopsy in two patients.
- Positron emission tomography/computed tomography (PET/CT) used for diagnosis in one patient.
Main Results:
- Atypical LVV cases presented with varied symptoms beyond typical cranial manifestations.
- Elevated alkaline phosphatase levels were a common hepatic abnormality observed in all reviewed patients.
- Alkaline phosphatase elevations demonstrated a rapid positive response to immunosuppressive treatment initiation.
Conclusions:
- Atypical LVV requires a high index of suspicion, especially when presenting with non-specific symptoms and liver enzyme abnormalities.
- Elevated alkaline phosphatase is a key indicator of hepatic involvement in LVV and responds well to treatment.
- Early diagnosis and initiation of immunosuppressive therapy are crucial for managing LVV and its diverse clinical manifestations.
Abstract:
Clinicians usually easily recognize cranial manifestations of giant cell arteritis (GCA) such as new-onset headache, jaw claudication, scalp tenderness, and abrupt changes in visual acuity or blindness; however, when presented with an aberrant clinical course, the diagnosis becomes more elusive. In addition to temporal arteries and other extracranial branches of the carotid arteries, large vessel vasculitis (LVV) can also affect other blood vessels including coronary arteries, aorta with its major branches, intracranial blood vessels, and hepatic arteries.Over time, the scope of the symptoms typically associated with LVV has broadened and includes cases of fever of unknown origin accompanied with other constitutional symptoms that can mimic a range of neoplastic and infectious diseases. In up to half of patients with atypical LVV, liver enzyme level elevations with a cholestatic pattern have been observed. Alkaline phosphatase level and γ-glutamyl transferase level elevations tend to be more prevalent in those LVV patients with vigorous inflammatory responses, particularly in those with fever and other nonspecific constitutional symptoms. These patients also have more profound anemia and thrombocytosis. With the exception of rare instances of vasculitides and granulomas affecting the liver tissue, liver biopsy is generally of little help and primarily shows nonspecific changes of fatty liver.In this article, we review 3 patients who were eventually diagnosed with atypical LVV. The diagnosis was confirmed with temporal artery biopsy in 2 patients and with positron emission tomography/computed tomography in 1 patient. The common hepatic abnormality observed in all patients was the elevation of alkaline phosphatase level, which tended to respond rapidly to initiation of immunosuppressive treatment.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

